Related Experiment Video
Updated: May 25, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Genomic screening for Chlamydophila pneumoniae-specific antigens using serum samples from patients with primary
Yumiko Yasui1, Izumi Yanatori, Yasuhiro Kawai
1Department of Molecular Genetics, Kawasaki Medical School, Kurashiki, Japan.
Abstract:
Chlamydophila pneumoniae, an obligate intracellular human pathogen, causes respiratory tract infections. The most common techniques used for the serological diagnosis of C. pneumoniae infections are microimmunofluorescence tests and commercial serological ELISA tests; these are based on the detection of antibodies against whole chlamydial elementary bodies and lipopolysaccharide/outer membrane protein, respectively. Identification of more specific and highly immunodominant antigens is essential for the development of new serodiagnostic assays. To identify novel specific antigens from C. pneumoniae, we screened 455 genes with unknown function in the genome of C. pneumoniae J138. Extracts of Saccharomyces cerevisiae cells expressing GFP-tagged C. pneumoniae proteins were subjected to Western blot analysis using serum samples from C. pneumoniae-infected patients as the primary antibodies. From this comprehensive analysis, 58 clones expressing C. pneumoniae open reading frames, including hypothetical proteins, were identified as antigens. These results have provided useful information for the development of new serological tools for the diagnosis for C. pneumoniae infections and for the development of vaccines in future.
Insights
Researchers screened Chlamydophila pneumoniae genes to find new antigens for improved diagnostic tests. This study identified 58 novel antigens, aiding the development of better tools for diagnosing C. pneumoniae infections.
Area of Science:
- Microbiology
- Immunology
- Genomics
Background:
- Chlamydophila pneumoniae causes respiratory infections, with current serological diagnostics relying on whole cell or LPS/OMP detection.
- Existing diagnostic methods for C. pneumoniae lack specificity, necessitating the identification of more precise antigens.
- Developing novel serodiagnostic assays requires identifying highly immunodominant and specific antigens from C. pneumoniae.
Discussion:
- A genome-wide screening of 455 C. pneumoniae genes with unknown functions was performed.
- Saccharomyces cerevisiae expressing GFP-tagged C. pneumoniae proteins were analyzed via Western blot using patient sera.
- This approach identified 58 C. pneumoniae open reading frames, including hypothetical proteins, as potential antigens.
Key Insights:
- Identified 58 novel C. pneumoniae antigens, including hypothetical proteins, through comprehensive genomic screening.
- Demonstrated the utility of yeast expression and Western blot for antigen discovery in bacterial pathogens.
- Provided a valuable resource of potential diagnostic and vaccine targets for C. pneumoniae.
Outlook:
- These findings facilitate the development of enhanced serological diagnostic tools for C. pneumoniae infections.
- The identified antigens offer promising candidates for future vaccine development against C. pneumoniae.
- Further research can validate these antigens for clinical application in diagnostics and therapeutics.
Related Concept Videos
Pneumonia III: Complications and Assessment
Bacterial Phylum Chlamydiae
